Views: 0 Author: Site Editor Publish Time: 2026-03-24 Origin: Site
Recent Metoree rankings put Mendel Company, Fain Industries, and Lonza Capsules at the top three globally. Meanwhile, Chinese brands like Jornen Machinery and LTPM CHINA are moving fast. They’re capturing serious mid-market share on the strength of competitive value. This isn’t a blip — it reflects a structural industry shift. Pharmaceutical companies are scaling up from small-batch production toward large-scale industrial manufacturing. And demand for the capsule filling machine in pharmaceutical industry keeps expanding with them.
Fully automatic models like the NJP-7500 now run the entire process without human intervention. Empty capsule loading, filling, locking — all closed loop. Single-shift output reaches tens of thousands of capsules. Consistency risk from manual handling is effectively eliminated. The global trend toward integrating capsule filling modules into solid dosage production lines is a structural one. It provides reliable, sustained growth momentum for the equipment market.
The move toward full automation in the capsule filling machine in pharmaceutical industry has two clear root causes. GMP regulation is tightening. Production capacity demands are expanding. Traditional manual machines simply cannot clear the bar for modern compliant manufacturing. Fully automatic models — the LTPM CHINA series being a good example — integrate feeding, separation, filling, locking, and discharge into a single standardized workflow.
By 2028, automatic equipment penetration rates will continue rising. Chinese manufacturer global market share is positioned to expand further. Three drivers explain the trajectory:
Demand side: The global capsule market sits at roughly $25 billion. End-user demand provides consistent upstream pull for equipment investment.
Efficiency side: Automation lifts production efficiency by an average of 50%. Equipment payback cycles compress accordingly.
Technology side: HEPA filtration and thermal distribution monitoring are becoming industry-standard specs, accelerating the overall baseline across the sector.
European and American brands like Mendel carry deep R&D process expertise. The procurement cost reflects that. Asian brands counter with flexible customization and adaptability to diverse production line configurations. Supply chain volatility does create some component cost variability — but overall risk remains manageable.
Budget and floor space are the two hard constraints. Semi-automatic machines are the right call here. LTPM CHINA’s semi-auto series offers convenient size changeover and a reasonable entry cost of around $6,000–$8,000. The risk is low and the learning curve is manageable.
The conversation shifts to balancing efficiency and cost. The NJ-1200 automatic entry-level model covers a fill range of 78 to 1,500mg, comes with CE and GMP dual certification, and can reduce required operators from four down to one. Payback cycles are shorter than most buyers expect.
High throughput and end-to-end compliance are the non-negotiables. The NJP-7500 or Syntegon fully automatic lines integrate deeply with complete solid dosage production workflows. HEPA filtration should be treated as a mandatory line item, not an optional upgrade.
Precise matching of equipment specifications to actual production volume is what keeps idle capacity low and operating costs under control. Assess your current output and your realistic 1-to-3-year growth trajectory before committing. Modular expandability is worth weighting heavily in that analysis.
The following comparison is based on Metoree rankings and industry reports. Prices are FOB USD reference ranges.
| Brand / Model | Main Advantages | Notable Weaknesses | Best Suited For | Price Range (USD) |
|---|---|---|---|---|
| Mendel Company (Bonapace) | Strong R&D capability; rich international pharma experience | Import-dependent; long lead times | Mid-to-large R&D pharmaceutical companies | $25,000 – $50,000 |
| LTPM CHINA (NJP Semi-Auto) | Stable operation; easy size changeover; GMP compliant | High-volume scenarios call for full auto upgrade | Small-to-mid pharma and supplement companies | $6,800 – $20,000 |
| Jornen Machinery | China Top 10; multi-industry compatibility; strong customization | International brand recognition still developing | Mid-scale integrated pharma packaging lines | $10,000 – $28,000 |
| Lonza Capsules | Capsule and filling integration; coverage across 100+ countries | Filling machines are not the core business | Supplement and softgel manufacturers | $15,000 – $35,000 |
| Syntegon Technology | High full-auto stability; ~6.2% global market share | High acquisition and maintenance cost | Large-scale industrial pharma operations | $40,000+ |
| NUPHA Capsules | European custom solutions; full HPMC and softgel coverage | Limited Asia market penetration | European and North American supplement companies | $20,000 – $40,000 |
Chinese brands carry a clear procurement cost advantage. European and American brands sustain their price premium through brand heritage and global service networks. That’s the honest picture. The right evaluation weighs capacity fit, compliance certifications, and after-sales support together — not just the purchase price in isolation.
There’s a real structural gap in the market. Western brands cost too much for many operations. Some Chinese alternatives still have room to grow on precision. Hanyoo’s NJP series is built specifically to fill that gap. Acquisition pricing is significantly more competitive than comparable Western equipment. Performance doesn’t take a hit.
Core Advantage One: Precision Dosing Module
Vibration disc combined with servo motor drive holds fill error to ≤1%. Compatible with powders, granules, and micro-pellets. Fill range covers 78 to 1,500mg. That flexibility matters when your product mix changes.
Core Advantage Two: Intelligent HMI Control Interface
The touchscreen supports one-touch changeover across all capsule sizes from 00 to 5#. Changeover time stays at or under 5 minutes. Standard configuration includes a GMP cleanroom chamber and HEPA filtration system at 99.997% purification efficiency.
Case Study One: A mid-scale pharmaceutical manufacturer in Jiangsu implemented the Hanyoo NJP-2000. Product reject rate dropped from 8% to 1.2%. Output increased by roughly 35%. Annual labor cost savings came in at approximately $200,000. Unplanned downtime fell by 40%.
Case Study Two: A Shanghai nutrition company moved from their previous semi-automatic setup to Hanyoo’s semi-auto model. Hourly output climbed from 1,500 to 4,000 capsules. Investment payback period landed at around 8 months. Powder utilization rate improved from 85% to 98%.
Both cases are backed by specific technical parameters and verified customer data.
Work through the selection process in this sequence:
Assess actual capacity requirements. Smaller operations should evaluate the NJ-1200. Larger lines should put the NJP-7500 and comparable high-throughput models through a rigorous spec review.
Get competitive quotes. Request pricing from at least three suppliers simultaneously. Verify GMP certification validity for each during the same process.
Run a machine trial. Arrange an on-site trial run focused on fill accuracy and changeover efficiency under your actual production conditions.
Cross-reference third-party evaluations. Use platform rankings like Metoree alongside peer case studies to build a grounded, objective brand picture.
Go deep on production planning. Work with a serious supplier — like Hanyoo — to map the full solution against your actual line configuration and growth trajectory.
The selection decision for a capsule filling machine in pharmaceutical industry has long-term consequences. It deserves thorough research time. Total lifecycle cost should drive the decision — not just the upfront purchase price.
Q: What does pricing actually look like for pharmaceutical capsule filling machines?
Semi-automatic models start around $6,800. High-end fully automatic systems can exceed $50,000. LTPM CHINA’s NJP semi-auto series runs $6,800–$20,000 and is well-matched to small and mid-sized operations. Fully automatic machines like the NJP-7500 range from $20,000 to $50,000 and suit scaled pharmaceutical production. Price differences primarily reflect automation level, throughput capacity, and brand positioning. During the inquiry stage, always roll after-sales service scope and freight terms into the total cost evaluation.
Q: How should a pharmaceutical company select the right automatic capsule filling machine?
Prioritize three things: capacity specifications, fill precision, and completeness of GMP certification. Verify that fill error is ≤1%, changeover time is ≤10 minutes, and capsule size compatibility covers the 00 to 5# range. Mid-budget operations should evaluate LTPM CHINA or Jornen Machinery seriously. Large-scale enterprises should assess industrial-grade platforms like Syntegon, factoring in long-term maintenance cost from the start. The basic decision process is clean: define your daily output target, arrange a live machine trial, and verify after-sales support before signing anything.
Q: Which brands dominate the pharmaceutical capsule filling machine market?
The main names are Mendel Company, LTPM CHINA, Jornen Machinery, Lonza Capsules, and Syntegon Technology. Mendel’s strength is R&D process depth. LTPM CHINA’s semi-auto series has a solid, consistent reputation with small-to-mid operations. Jornen stands out on multi-industry compatibility. Syntegon suits large industrial-scale lines — though acquisition and maintenance costs are high. Emerging brands like Hanyoo are building real market credibility through consistent precision performance and responsive customer service. When evaluating, give real weight to market share data, verified customer cases, and after-sales network coverage. Spec sheets alone don’t tell the full story.
